Artwork for podcast Pathfinders in Biopharma
What’s Material in ESG for Biopharma Firms?
Episode 74th May 2021 • Pathfinders in Biopharma • RBC Capital Markets
00:00:00 00:18:32

Share Episode


For biopharma companies, ESG commitments can look considerably different from other sectors. We spoke with the team of ESG leads at Gilead Sciences to understand the five key components driving its ESG strategy, how it’s evolved and how it impacts their business.